A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function

[1]  M. Obokata,et al.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease , 2017, European heart journal.

[2]  E. Schwammenthal,et al.  Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study , 2017, European heart journal cardiovascular Imaging.

[3]  Denis Chemla,et al.  Pulmonary hypertension due to left heart disease. , 2017, Archives of cardiovascular diseases.

[4]  J. Elliott,et al.  Plasma N‐Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats , 2017, Journal of veterinary internal medicine.

[5]  M. Guazzi,et al.  Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives. , 2017, Journal of the American College of Cardiology.

[6]  L. Lerman,et al.  Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction. , 2017, Circulation. Heart failure.

[7]  R. Wachter,et al.  Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. , 2016, European heart journal.

[8]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[9]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[10]  W. Linke,et al.  Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction , 2016, Circulation. Heart failure.

[11]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[12]  D. Kass,et al.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap , 2016, Circulation.

[13]  D. Duncker,et al.  Animal models of heart failure with preserved ejection fraction , 2016, Netherlands Heart Journal.

[14]  W. Paulus,et al.  Understanding heart failure with preserved ejection fraction: where are we today? , 2016, Netherlands Heart Journal.

[15]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[16]  R. Wachter,et al.  Left ventricular heart failure and pulmonary hypertension , 2015, European heart journal.

[17]  W. Linke,et al.  A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. , 2015, American journal of physiology. Heart and circulatory physiology.

[18]  A. Tucker,et al.  Regulation of L-type calcium channel by phospholemman in cardiac myocytes. , 2015, Journal of molecular and cellular cardiology.

[19]  Peter Van Buren,et al.  Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin , 2015, Circulation.

[20]  P. Steendijk,et al.  Mild hypothermia induces incomplete left ventricular relaxation despite spontaneous bradycardia in pigs , 2015, Acta physiologica.

[21]  V. Melenovský,et al.  Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction , 2015, Circulation. Heart failure.

[22]  T. Bányász,et al.  Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  Michael A. Burke,et al.  Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[24]  B. Borlaug,et al.  The pathophysiology of heart failure with preserved ejection fraction , 2014, Nature Reviews Cardiology.

[25]  B. Borlaug,et al.  Invasive hemodynamic characterization of heart failure with preserved ejection fraction. , 2014, Heart failure clinics.

[26]  D. Kass,et al.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. , 2014, Circulation research.

[27]  B. Borlaug,et al.  Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges , 2014, Current Cardiology Reports.

[28]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[29]  J. Dukes-McEwan,et al.  Left atrial size, atrial function and left ventricular diastolic function in cats with hypertrophic cardiomyopathy. , 2014, The Journal of small animal practice.

[30]  Milton Packer,et al.  Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.

[31]  P. Chang,et al.  Heart failure with preserved ejection fraction: an ongoing enigma. , 2014, Cardiology clinics.

[32]  Sanjiv J. Shah,et al.  Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial , 2014, Circulation. Heart failure.

[33]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[34]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[35]  F. Zannad,et al.  Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease. , 2013, Journal of the American Veterinary Medical Association.

[36]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[37]  David D McManus,et al.  Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. , 2013, The American journal of medicine.

[38]  Manesh R. Patel,et al.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.

[39]  R. Wachter,et al.  Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. , 2013, JAMA.

[40]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[41]  S. Houser,et al.  Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. , 2012, Journal of molecular and cellular cardiology.

[42]  J. Dubois-Randé,et al.  Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs , 2012, Basic Research in Cardiology.

[43]  Xiaobai Li,et al.  Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy. , 2012, American journal of veterinary research.

[44]  D. Kass,et al.  Invasive hemodynamic assessment in heart failure. , 2011, Cardiology clinics.

[45]  S. Ommen,et al.  Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction , 2011, Heart.

[46]  W. Paulus,et al.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.

[47]  R. Vasan,et al.  Epidemiology and clinical course of heart failure with preserved ejection fraction , 2011, European journal of heart failure.

[48]  R. Sacco,et al.  Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49]  E. Catherwood,et al.  Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. , 2010, The American journal of cardiology.

[50]  J. King,et al.  Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance* , 2010, Critical care medicine.

[51]  M. Penicka,et al.  Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis. , 2010, Journal of the American College of Cardiology.

[52]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[53]  E. Weibel,et al.  American Thoracic Society Documents An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure , 2010 .

[54]  A. Henning,et al.  Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. , 2009, Journal of the American College of Cardiology.

[55]  V. Roger,et al.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. , 2009, Journal of the American College of Cardiology.

[56]  Yu Ting Tan,et al.  The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. , 2009, Journal of the American College of Cardiology.

[57]  A. Cohen-Solal,et al.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.

[58]  Thor Edvardsen,et al.  Determinants of Left Ventricular Early-Diastolic Lengthening Velocity: Independent Contributions From Left Ventricular Relaxation, Restoring Forces, and Lengthening Load , 2009, Circulation.

[59]  V. Roger,et al.  Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. , 2009, Journal of the American College of Cardiology.

[60]  J. Gaughan,et al.  Multicenter Comparative Study of Conventional Mechanical Gas Ventilation to Tidal Liquid Ventilation in Oleic Acid Injured Sheep , 2008, ASAIO journal.

[61]  Krishnaswamy Chandrasekaran,et al.  Twist mechanics of the left ventricle: principles and application. , 2008, JACC. Cardiovascular imaging.

[62]  D. Kass,et al.  Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota , 2007, Circulation.

[63]  D. Kass,et al.  Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.

[64]  Serguei V. S. Pakhomov,et al.  Systolic and diastolic heart failure in the community. , 2006, JAMA.

[65]  J. Fleg,et al.  Heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[66]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[67]  S. Vatner,et al.  Paradoxical Cellular Ca2+ Signaling in Severe but Compensated Canine Left Ventricular Hypertrophy , 2005, Circulation research.

[68]  M. Redfield,et al.  Ventricular Structure and Function in Aged Dogs With Renal Hypertension: A Model of Experimental Diastolic Heart Failure , 2005, Circulation.

[69]  W. Gaasch,et al.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.

[70]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[71]  J. Häggström,et al.  Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement. , 2002, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[72]  Steven R Houser,et al.  L-Type Ca2+ Channel Density and Regulation Are Altered in Failing Human Ventricular Myocytes and Recover After Support With Mechanical Assist Devices , 2002, Circulation research.

[73]  Steven W. Lee,et al.  Progression of Systolic Abnormalities in Patients With “Isolated” Diastolic Heart Failure and Diastolic Dysfunction , 2002, Circulation.

[74]  A. Mattioli,et al.  Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function. , 2000, The American journal of cardiology.

[75]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[76]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[77]  S. Houser,et al.  Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. , 1997, Journal of molecular and cellular cardiology.

[78]  G. Aurigemma,et al.  Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. , 1995, Circulation.

[79]  M R Wolfson,et al.  Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates. , 1992, Journal of applied physiology.

[80]  S. Vatner,et al.  Subendomyocardial Exhaustion of Blood Flow Reserve and Increased Fibrosis in Conscious Dogs With Heart Failure , 1989, Circulation research.

[81]  S. Vatner,et al.  Isoproterenol-induced alterations in myocardial blood flow, systolic and diastolic function in conscious dogs with heart failure. , 1989, Circulation.

[82]  D. Kass,et al.  Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. , 1987, Circulation.

[83]  G. Mudge,et al.  Factors Contributing to Altered Left Ventricular Diastolic Properties During Angina Pectoris , 1979, Circulation.

[84]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[85]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[86]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[87]  B. Borlaug.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[88]  K. McDonald,et al.  Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function. , 2013, Journal of applied physiology.

[89]  Mary G. George,et al.  A Policy Statement From the American Heart Association Recommendations for the Implementation of Telemedicine Within Stroke , 2009 .

[90]  K. McDonald,et al.  Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O 2 balance and diastolic function , 2012 .

[91]  M. Cheitlin.  Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction , 2009 .

[92]  W. McDicken,et al.  Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy. , 2006, Journal of veterinary internal medicine.

[93]  T. Shaffer,et al.  Use of a touch sensitive screen and computer assisted image analysis for quantitation of developmental changes in pulmonary structure , 1990, Pediatric pulmonology.

[94]  S. Houser,et al.  Contractile properties of single isolated feline ventriculocytes. , 1988, American Journal of Physiology.

[95]  R. Jennings,et al.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[96]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[97]  北村 聖.  "The New England Journal of Medicine". , 1962, British medical journal.